These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 2554366

  • 1. 1-[4-[3-[4-[bis(4-fluorophenyl)hydroxymethyl]-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone(AHR-5333): a selective human blood neutrophil 5-lipoxygenase inhibitor.
    Graff G, Anderson LA.
    Prostaglandins; 1989 Oct; 38(4):473-96. PubMed ID: 2554366
    [Abstract] [Full Text] [Related]

  • 2. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo.
    Tateson JE, Randall RW, Reynolds CH, Jackson WP, Bhattacherjee P, Salmon JA, Garland LG.
    Br J Pharmacol; 1988 Jun; 94(2):528-39. PubMed ID: 2840160
    [Abstract] [Full Text] [Related]

  • 3. Metabolism of arachidonic acid through the 5-lipoxygenase pathway in normal human peritoneal macrophages.
    Laviolette M, Carreau M, Coulombe R, Cloutier D, Dupont P, Rioux J, Braquet P, Borgeat P.
    J Immunol; 1988 Sep 15; 141(6):2104-9. PubMed ID: 2844895
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of leukotriene (LT) and hydroxy eicosatetraenoic acid (HETE) synthesis in human leukocytes in vitro: effect of arachidonic acid concentration.
    Fruteau de Laclos B, Braquet P, Borgeat P.
    Prostaglandins Leukot Med; 1984 Jan 15; 13(1):47-52. PubMed ID: 6324240
    [Abstract] [Full Text] [Related]

  • 5. Auranofin stimulates LTA hydrolase and inhibits 5-lipoxygenase/LTA synthase activity of isolated human neutrophils.
    Betts WH, Hurst NP, Murphy GA, Cleland LG.
    Biochem Pharmacol; 1990 Apr 01; 39(7):1233-7. PubMed ID: 2157444
    [Abstract] [Full Text] [Related]

  • 6. Differential inhibitory effects of auranofin on leukotriene B4 and leukotriene C4 formation by human polymorphonuclear leukocytes.
    Honda Z, Iizasa T, Morita Y, Matsuta K, Nishida Y, Miyamoto T.
    Biochem Pharmacol; 1987 May 01; 36(9):1475-81. PubMed ID: 3034290
    [Abstract] [Full Text] [Related]

  • 7. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
    Carty TJ, Sweeney FJ, Griffiths RJ, Eskra JD, Ernest MJ, Pillar JS, Cheng JD, Loose LD, Joseph PA, Pazoles PP, Moore PF, Nagahisa A, Murase S, Kadin SB.
    Inflamm Res; 1997 May 01; 46(5):168-79. PubMed ID: 9197987
    [Abstract] [Full Text] [Related]

  • 8. Preferential inhibition of 5-lipoxygenase activity by manoalide.
    De Vries GW, Amdahl L, Mobasser A, Wenzel M, Wheeler LA.
    Biochem Pharmacol; 1988 Aug 01; 37(15):2899-905. PubMed ID: 2840081
    [Abstract] [Full Text] [Related]

  • 9. Comparison of 5- and 15-lipoxygenase activities in blood and alveolar leukocyte preparations from normal subjects and patients with eosinophilia.
    Laviolette M, Picard S, Braquet P, Borgeat P.
    Prostaglandins Leukot Med; 1986 Aug 01; 23(2-3):191-9. PubMed ID: 3020586
    [Abstract] [Full Text] [Related]

  • 10. Modulation of alveolar macrophage-derived 5-lipoxygenase products by the sulfhydryl reactant, N-ethylmaleimide.
    Peters-Golden M, Shelly C.
    J Biol Chem; 1987 Aug 05; 262(22):10594-600. PubMed ID: 3112148
    [Abstract] [Full Text] [Related]

  • 11. Effect of indomethacin on arachidonic acid metabolism in human leukocytes stimulated ex vivo.
    Docherty JC, Wilson TW.
    Clin Pharmacol Ther; 1991 Mar 05; 49(3):294-9. PubMed ID: 1848800
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of leukotriene formation in human leukocytes by halothane.
    Yamaoka A, Sumimoto H, Takeshige K, Itoh T, Isobe R, Yoshitake J, Minakami S.
    Biochim Biophys Acta; 1987 Apr 24; 918(3):284-92. PubMed ID: 3032266
    [Abstract] [Full Text] [Related]

  • 13. Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models.
    Ku EC, Raychaudhuri A, Ghai G, Kimble EF, Lee WH, Colombo C, Dotson R, Oglesby TD, Wasley JW.
    Biochim Biophys Acta; 1988 Apr 15; 959(3):332-42. PubMed ID: 2833314
    [Abstract] [Full Text] [Related]

  • 14. Anthralin (1,8-dihydroxyanthrone) is a potent inhibitor of leukotriene production and LTB4-omega oxidation by human neutrophils.
    Schröder JM.
    J Invest Dermatol; 1986 Nov 15; 87(5):624-9. PubMed ID: 3021863
    [Abstract] [Full Text] [Related]

  • 15. Production of metabolic products of arachidonic acid during cell-cell interactions.
    Marcus AJ, Safier LB, Broekman MJ, Ullman HL, Islam N, Sorrell TC, Serhan CN, Weissmann G, Oglesby TD, Gorman RR.
    J Allergy Clin Immunol; 1984 Sep 15; 74(3 Pt 2):338-42. PubMed ID: 6088611
    [Abstract] [Full Text] [Related]

  • 16. Time-dependent utilization of platelet arachidonic acid by the neutrophil in formation of 5-lipoxygenase products in platelet-neutrophil co-incubations.
    Antoine C, Murphy RC, Henson PM, Maclouf J.
    Biochim Biophys Acta; 1992 Oct 30; 1128(2-3):139-46. PubMed ID: 1329972
    [Abstract] [Full Text] [Related]

  • 17. Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products.
    Tornhamre S, Edenius C, Smedegård G, Sjöquist B, Lindgren JA.
    Eur J Pharmacol; 1989 Oct 10; 169(2-3):225-34. PubMed ID: 2572437
    [Abstract] [Full Text] [Related]

  • 18. In vitro inhibition of leukotriene B4 formation by exogeneous 5-lipoxygenase inhibitors is associated with enhanced generation of 15-hydroxy-eicosatetraenoic acid (15-HETE) by human neutrophils.
    Fogh K, Herlin T, Kragballe K.
    Arch Dermatol Res; 1988 Oct 10; 280(7):430-6. PubMed ID: 2849922
    [Abstract] [Full Text] [Related]

  • 19. Production of arachidonic acid lipoxygenase products during platelet-neutrophil interactions.
    Marcus AJ, Broekman MJ, Safier LB, Ullman HL, Islam N, Serhan CN, Weissmann G.
    Clin Physiol Biochem; 1984 Oct 10; 2(2-3):78-83. PubMed ID: 6435929
    [Abstract] [Full Text] [Related]

  • 20. Stimulation of 5-lipoxygenase activity in polymorphonuclear leukocytes of rats by caseinate treatment.
    Chang WC, Su GW.
    Biochem Pharmacol; 1987 Sep 15; 36(18):3033-6. PubMed ID: 2820429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.